Literature DB >> 15491965

Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases.

Binnaz Handan Ozdemir1, Zafer Akcali, Mehmet Haberal.   

Abstract

Our aim was to study the effect of hypercholesterolemia on angiogenesis induced by breast carcinoma. Of 51 patients with invasive ductal carcinoma, 28 had hypercholesterolemia and 23 had normocholesterolemia. The intratumoral microvessel density (MVD) was evaluated by using anti-CD31 antibody. The expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) on endothelial and tumor cells was examined and graded semiquantitatively. Patients with normocholesterolemia had a higher MVD (76.4 +/- 8.2) than those with hypercholesterolemia (54.6 +/- 5.1) (P < .01). The risks of recurrence and distant metastasis were higher in patients with normocholesterolemia than in patients with hypercholesterolemia (P < .01). Patients with hypercholesterolemia showed lower expression of endothelial VEGF and bFGF than patients with normocholesterolemia (P < .05 and P < .01, respectively). In addition, tumoral bFGF and VEGF expression showed negative correlation with the presence of hypercholesterolemia (P < .01). We suggest that hypercholesterolemia impairs angiogenesis by suppressing endothelial and tumoral bFGF and VEGF expression and, therefore, lowers the risk of metastases in cases of invasive breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491965     DOI: 10.1309/HW2M-YB5T-VF4A-M0Y4

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Authors:  Thomas P Ahern; Lars Pedersen; Maja Tarp; Deirdre P Cronin-Fenton; Jens Peter Garne; Rebecca A Silliman; Henrik Toft Sørensen; Timothy L Lash
Journal:  J Natl Cancer Inst       Date:  2011-08-02       Impact factor: 13.506

Review 2.  Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers.

Authors:  Jennifer L Herrmann; Yevgeniya Byekova; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2011-03-29       Impact factor: 8.679

3.  Hypercholesterolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: possible role of VEGF downregulation in brain.

Authors:  Lei Xi; Shobha Ghosh; Xiaoyin Wang; Anindita Das; Frank P Anderson; Rakesh C Kukreja
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

4.  Statin use in primary inflammatory breast cancer: a cohort study.

Authors:  T M Brewer; H Masuda; D D Liu; Y Shen; P Liu; T Iwamoto; K Kai; C M Barnett; W A Woodward; J M Reuben; P Yang; G N Hortobagyi; N T Ueno
Journal:  Br J Cancer       Date:  2013-07-02       Impact factor: 7.640

5.  Do statins increase and Mediterranean diet decrease the risk of breast cancer?

Authors:  Michel de Lorgeril; Patricia Salen
Journal:  BMC Med       Date:  2014-06-05       Impact factor: 8.775

6.  Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.

Authors:  Cuiling Qi; Qin Zhou; Bin Li; Yang Yang; Liu Cao; Yuxiang Ye; Jiangchao Li; Yi Ding; Huiping Wang; Jintao Wang; Xiaodong He; Qianqian Zhang; Tian Lan; Kenneth Ka Ho Lee; Weidong Li; Xiaoyu Song; Jia Zhou; Xuesong Yang; Lijing Wang
Journal:  Oncotarget       Date:  2014-10-30

7.  Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis.

Authors:  Mohammed Habis; Kristen Wroblewski; Michael Bradaric; Nadia Ismail; S Diane Yamada; Lacey Litchfield; Ernst Lengyel; Iris L Romero
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

8.  Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.

Authors:  Stefan Nickels; Alina Vrieling; Petra Seibold; Judith Heinz; Nadia Obi; Dieter Flesch-Janys; Jenny Chang-Claude
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

9.  P-selectin-mediated platelet adhesion promotes tumor growth.

Authors:  Cuiling Qi; Bo Wei; Weijie Zhou; Yang Yang; Bin Li; Simei Guo; Jialin Li; Jie Ye; Jiangchao Li; Qianqian Zhang; Tian Lan; Xiaodong He; Liu Cao; Jia Zhou; Jianguo Geng; Lijing Wang
Journal:  Oncotarget       Date:  2015-03-30

10.  Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.

Authors:  Cuiling Qi; Yang Yang; Yongxia Yang; Jialin Li; Qin Zhou; Yinxin Wen; Cuiling Zeng; Lingyun Zheng; Qianqian Zhang; Jiangchao Li; Xiaodong He; Jia Zhou; Chunkui Shao; Lijing Wang
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.